Original Article

High Pathogenic Potential of Low-Affinity Autoantibodies in Experimental Autoimmune Hemolytic Anemia

Correspondence to: Shozo Izui, Department of Pathology, Centre Médical Universitaire, University of Geneva, 1211 Geneva 4, Switzerland. Tel:41-22-70-25-741 Fax:41-22-70-25-746 E-mail:shozo.izui{at}medecine.unige.ch.

To assess the potency of low-affinity anti–red blood cell (RBC) autoantibodies in the induction of anemia, we generated an immunoglobulin (Ig)G2a class-switch variant of a 4C8 IgM anti–mouse RBC autoantibody, and compared its pathogenic potential with that of its IgM isotype and a high-affinity 34-3C IgG2a autoantibody. The RBC-binding activity of the 4C8 IgG2a variant was barely detectable, at least 1,000 times lower than that of its IgM isotype, having a high-binding avidity, and that of the 34-3C IgG2a monoclonal antibody (mAb). This low-affinity feature of the 4C8 mAb was consistent with the lack of detection of opsonized RBCs in the circulating blood from the 4C8 IgG2a–injected mice. However, the 4C8 IgG2a variant was highly pathogenic, as potent as its IgM isotype and the 34-3C IgG2a mAb, due to its capacity to interact with Fc receptors involved in erythrophagocytosis. In addition, our results indicated that the pentameric form of the low-affinity IgM isotype, by promoting the binding and agglutination of RBCs, is critical for its pathogenic activity. Demonstration of the remarkably high pathogenic potency of low-affinity autoantibodies, if combined with appropriate heavy chain effector functions, highlights the critical role of the Ig heavy chain constant regions, but the relatively minor role of autoantigen-binding affinities, in autoimmune hemolytic anemia.

Key Words: autoantibody, autoimmune hemolytic anemia, Fc receptor, Kupffer cell, knockout mouse

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Baudino, L., Nimmerjahn, F., Azeredo da Silveira, S., Martinez-Soria, E., Saito, T., Carroll, M., Ravetch, J. V., Verbeek, J. S., Izui, S. (2008). Differential Contribution of Three Activating IgG Fc Receptors (Fc{gamma}RI, Fc{gamma}RIII, and Fc{gamma}RIV) to IgG2a- and IgG2b-Induced Autoimmune Hemolytic Anemia in Mice. J. Immunol. 180: 1948-1953 [Abstract] [Full Text]  
• COUTELIER, J.-P., DETALLE, L., MUSAJI, A., MEITE, M., IZUI, S. (2007). Two-Step Mechanism of Virus-induced Autoimmune Hemolytic Anemia. Ann. N. Y. Acad. Sci. 1109: 151-157 [Abstract] [Full Text]  
• Baudino, L., Fossati-Jimack, L., Chevalley, C., Martinez-Soria, E., Shulman, M. J., Izui, S. (2007). IgM and IgA anti-erythrocyte autoantibodies induce anemia in a mouse model through multivalency-dependent hemagglutination but not through complement activation. Blood 109: 5355-5362 [Abstract] [Full Text]  
• Schirmer, D. A., Song, S.-C., Baliff, J. P., Harbers, S. O., Clynes, R. A., Krop-Watorek, A., Halverson, G. R., Czerwinski, M., Spitalnik, S. L. (2007). Mouse models of IgG- and IgM-mediated hemolysis. Blood 109: 3099-3107 [Abstract] [Full Text]  
• Kim, D. D., Miwa, T., Song, W.-C. (2006). Retrovirus-Mediated Over-Expression of Decay-Accelerating Factor Rescues Crry-Deficient Erythrocytes from Acute Alternative Pathway Complement Attack. J. Immunol. 177: 5558-5566 [Abstract] [Full Text]  
• Genton, C., Wang, Y., Izui, S., Malissen, B., Delsol, G., Fournie, G. J., Malissen, M., Acha-Orbea, H. (2006). The Th2 Lymphoproliferation Developing in LatY136F Mutant Mice Triggers Polyclonal B Cell Activation and Systemic Autoimmunity. J. Immunol. 177: 2285-2293 [Abstract] [Full Text]  
• Kikuchi, S., Amano, H., Amano, E., Fossati-Jimack, L., Santiago-Raber, M.-L., Moll, T., Ida, A., Kotzin, B. L., Izui, S. (2005). Identification of 2 major loci linked to autoimmune hemolytic anemia in NZB mice. Blood 106: 1323-1329 [Abstract] [Full Text]  
• Uchida, J., Hamaguchi, Y., Oliver, J. A., Ravetch, J. V., Poe, J. C., Haas, K. M., Tedder, T. F. (2004). The Innate Mononuclear Phagocyte Network Depletes B Lymphocytes through Fc Receptor-dependent Mechanisms during Anti-CD20 Antibody Immunotherapy. J. Exp. Med. 199: 1659-1669 [Abstract] [Full Text]  
• Jordan, M. B., van Rooijen, N., Izui, S., Kappler, J., Marrack, P. (2003). Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model. Blood 101: 594-601 [Abstract] [Full Text]  
• Molina, H., Miwa, T., Zhou, L., Hilliard, B., Mastellos, D., Maldonado, M. A., Lambris, J. D., Song, W.-C. (2002). Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Blood 100: 4544-4549 [Abstract] [Full Text]  
• Miwa, T., Zhou, L., Hilliard, B., Molina, H., Song, W.-C. (2002). Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack. Blood 99: 3707-3716 [Abstract] [Full Text]  
• da Silveira, S. A., Kikuchi, S., Fossati-Jimack, L., Moll, T., Saito, T., Verbeek, J. S., Botto, M., Walport, M. J., Carroll, M., Izui, S. (2002). Complement Activation Selectively Potentiates the Pathogenicity of the IgG2b and IgG3 Isotypes of a High Affinity Anti-Erythrocyte Autoantibody. J. Exp. Med. 195: 665-672 [Abstract] [Full Text]  
• Nardi, M., Karpatkin, S. (2000). Antiidiotype Antibody against Platelet Anti-GPIIIa Contributes to the Regulation of Thrombocytopenia in HIV-1-ITP Patients. J. Exp. Med. 191: 2093-2100 [Abstract] [Full Text]  
• Fossati-Jimack, L., Ioan-Facsinay, A., Reininger, L., Chicheportiche, Y., Watanabe, N., Saito, T., Hofhuis, F. M. A., Gessner, J. E., Schiller, C., Schmidt, R. E., Honjo, T., Verbeek, J. S., Izui, S. (2000). Markedly Different Pathogenicity of Four Immunoglobulin G Isotype-Switch Variants of an Antierythrocyte Autoantibody Is Based on Their Capacity to Interact In Vivo with the Low-Affinity Fc{gamma} Receptor III. J. Exp. Med. 191: 1293-1302 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS